Home

Latest QBI News on COVID-19

On January 25, 2021: New preclinical data shows a promising therapeutic for SARS-CoV-2 infection: Plitidepsin (Aplidin).

WHAT IS QBI?

QBI fosters collaborations across the biomedical and the physical sciences, seeking quantitative methods to address pressing problems in biology and biomedicine. Watch the video:

Visionary funders are needed to support this unprecedented collaboration of scientists. It may be that this human tragedy is what finally unifies us to find a solution together.

SF Chronicle on January 25, 2021: After a yearlong search for existing drugs that might help COVID-19 patients, a promising candidate was identified by scientists at UCSF.

Biorxiv on January 24, 2021: Scientists share in vitro data demonstrating antiviral activity of plitidepsin.

Women scientists from the QBI Coronavirus Research Group speak to the sense of urgency that inspired such a multidisciplinary team to gather and strategically fight the COVID-19 pandemic.

ABC 7 News on February 16, 2021: QCRG scientists are studying the mutated genes of the COVID-19 variants, hoping to figure out the best drugs to kill it.

QBI SCIENTISTS

March 6, 2019

Interview With Natalia Jura

Alexa Rocourt Read More

QBI SCIENTISTS

May 29, 2019

Interview With Danica Fujimori

Alexa Rocourt Read More

QBI SCIENTISTS

December 29, 2017

Interview With Brian Shoichet

Alexa Rocourt Read More

QBI SCIENTISTS

February 27, 2019

Interview With Matt Jacobson

Alexa Rocourt Read More

QBI SCIENTISTS

July 3, 2018

Interview With Kevan Shokat

Alexa Rocourt Read More

QBI SCIENTISTS

April 18, 2018

Interview With David Agard

ALEXA ROCOURT Read More

QBI SCIENTISTS

April 11, 2018

Interview With Jack Taunton

ALEXA ROCOURT Read More

QBI SCIENTISTS

February 14, 2018

Interview with Tanja Kortemme

Alexa Rocourt Read More

QBI SCIENTISTS

November 29, 2017

Interview With Charles Craik

Alexa Rocourt Read More

Home

Latest QBI News on COVID-19

WHAT IS QBI?

QBI fosters collaborations across the biomedical and the physical sciences, seeking quantitative methods to address pressing problems in biology and biomedicine. Watch the video:

Donate to COVID-19 research

Visionary funders are needed to support this unprecedented collaboration of scientists. It may be that this human tragedy is what finally unifies us to find a solution together.

Cancer drug Aplidin shows promise as COVID therapy

SF Chronicle on January 25, 2021: After a yearlong search for existing drugs that might help COVID-19 patients, a promising candidate was identified by scientists at UCSF.

Plitidepsin 100 times more potent than remdesivir in human epithelial cells

Biorxiv on January 24, 2021: Scientists share in vitro data demonstrating antiviral activity of plitidepsin.

The Women of QCRG

Women scientists from the QBI Coronavirus Research Group speak to the sense of urgency that inspired such a multidisciplinary team to gather and strategically fight the COVID-19 pandemic.

Secret to killing COVID-19 variants may lie in targeting human protein

ABC 7 News on February 16, 2021: QCRG scientists are studying the mutated genes of the COVID-19 variants, hoping to figure out the best drugs to kill it.

QBI SCIENTISTS

Interview With Natalia Jura

QBI SCIENTISTS

Interview With Danica Fujimori

QBI SCIENTISTS

Interview With Brian Shoichet

QBI SCIENTISTS

Interview With Matt Jacobson

QBI SCIENTISTS

Interview With Kevan Shokat

QBI SCIENTISTS

Interview With David Agard

QBI SCIENTISTS

Interview With Jack Taunton

QBI SCIENTISTS

Interview with Tanja Kortemme

QBI SCIENTISTS

Interview With Charles Craik

February

Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics

March

Transcription factor binding to DNA mismatches – a potential driver of increased mutagenesis at regulatory sites

April

A universal mechanism for activation of MST2 during Hippo signal transduction

Support COVID-19
Research

Be part of the solution

Home

Latest QBI News on COVID-19

WHAT IS QBI?

Donate to COVID-19 research

Cancer drug Aplidin shows promise as COVID therapy

Plitidepsin 100 times more potent than remdesivir in human epithelial cells

The Women of QCRG

Secret to killing COVID-19 variants may lie in targeting human protein

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

QBI SCIENTISTS

February

Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics

March

Transcription factor binding to DNA mismatches – a potential driver of increased mutagenesis at regulatory sites

April

A universal mechanism for activation of MST2 during Hippo signal transduction

Support COVID-19Research

Be part of the solution

Support COVID-19
Research